{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:33:54Z","timestamp":1792103634000,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacl.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:58:50Z","timestamp":1739465930000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9008-8506","authenticated-orcid":false,"given":"Byung Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-2822","authenticated-orcid":false,"given":"Jeonggyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.02.007_bib0001","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein (a) diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2023.04.012","article-title":"Frequent questions and responses on the 2022 lipoprotein (a) consensus statement of the European Atherosclerosis Society","volume":"374","author":"Kronenberg","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.02.007_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamacardio.2020.5398","article-title":"Clinical utility of lipoprotein (a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0005","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with lp (a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.02.007_bib0006","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/eurheartj\/ehy902","article-title":"High lipoprotein (a) and high risk of mortality","volume":"40","author":"Langsted","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.02.007_bib0007","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/eurjpc\/zwac271","article-title":"Lipoprotein (a) -related cardiovascular and all-cause mortalities in Korean adults","volume":"30","author":"Kim","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jacl.2018.02.007","article-title":"Elevated lipoprotein (a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease","volume":"12","author":"Verweij","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.atherosclerosis.2013.04.015","article-title":"Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study","volume":"229","author":"Erbel","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2021.06.035","article-title":"Risk markers for limited coronary artery calcium in persons with significant aortic valve calcium (from the Multi-ethnic Study of Atherosclerosis)","volume":"156","author":"Razavi","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117405","article-title":"The association of lipoprotein (a) with coronary artery calcification: a systematic review and meta-analysis","volume":"388","author":"Qiu","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0014","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/eurjpc\/zwae043","article-title":"The association of lipoprotein (a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis","volume":"31","author":"Martignoni","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacc.2021.11.058","article-title":"Independent association of lipoprotein (a) and coronary artery calcification with atherosclerotic cardiovascular risk","volume":"79","author":"Mehta","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0016","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/TCRM.S374372","article-title":"Correlations between coronary artery disease, coronary artery calcium score, and lipoprotein (a) level in Korea","author":"Kim","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jacl.2025.02.007_bib0017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2022.04.004","article-title":"Lipoprotein (a): an underestimated inflammatory mastermind","volume":"349","author":"Dzobo","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2022.04.009","article-title":"Beyond fibrinolysis: the confounding role of Lp (a) in thrombosis","volume":"349","author":"Boffa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154960","article-title":"Lipoprotein (a)-mediated vascular calcification: population-based and in vitro studies","volume":"127","author":"Peng","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2025.02.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024870","article-title":"Lipoprotein (a) and subclinical vascular and valvular calcification on cardiac computed tomography: the atherosclerosis risk in communities study","volume":"11","author":"Obisesan","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2025.02.007_bib0021","doi-asserted-by":"crossref","first-page":"e71673","DOI":"10.1371\/journal.pone.0071673","article-title":"Serum lipoprotein (a) positively correlates with coronary artery calcification in low-risk Chinese Han patients: a study from a single center","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2025.02.007_bib0022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2016.07.219","article-title":"Increased risk of coronary artery calcification progression in subjects with high baseline lp (a) levels: the Kangbuk Samsung Health Study","volume":"222","author":"Cho","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0023","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.0000159263.50305.BD","article-title":"Hobbs HH. Lipoprotein (a) and apolipoprotein (a) isoforms: no association with coronary artery calcification in the Dallas Heart Study","volume":"111","author":"Guerra","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.02.007_bib0024","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.numecd.2023.07.015","article-title":"Predictive value of lipoprotein (a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: a systematic review and meta-analysis","volume":"33","author":"Vazirian","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0025","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.02.007_bib0026","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.5551\/jat.RV22009","article-title":"Coronary artery calcium in assessment of atherosclerotic cardiovascular disease risk and its role in primary prevention","volume":"30","author":"Hisamatsu","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2025.02.007_bib0027","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.02.007_bib0029","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12997\/jla.2019.8.2.78","article-title":"2018 Guidelines for the management of dyslipidemia in Korea","volume":"8","author":"Rhee","year":"2019","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacl.2025.02.007_bib0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.CIR.0000157730.94423.4B","article-title":"Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"111","author":"Bild","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.02.007_bib0031","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamacardio.2021.2321","article-title":"Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: the multi-ethnic study of atherosclerosis","volume":"6","author":"Patel","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0032","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","year":"2009","journal-title":"JAMA: J Am Med Assoc"},{"key":"10.1016\/j.jacl.2025.02.007_bib0033","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Rosamond WD, Folsom AR. Lipoprotein (a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacl.2025.02.007_bib0034","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/ATVBAHA.118.311857","article-title":"Lipoprotein (a) and risk of ischemic stroke in the REGARDS study","volume":"39","author":"Arora","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.02.007_bib0036","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","article-title":"Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure","volume":"57","author":"Okura","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacl.2025.02.007_bib0037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1445-5994.2008.01864.x","article-title":"Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study","volume":"39","author":"Barr","year":"2009","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacl.2025.02.007_bib0038","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/JOM.0b013e3181a86671","article-title":"How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data","volume":"51","author":"Short","year":"2009","journal-title":"J Occup Environ Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:29:45Z","timestamp":1762561785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1933287425000303"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.02.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}